Pfizer and partner BioNTech confirmed they will seek approval from the Food and Drug Administration on Friday for emergency usage of their new COVID-19 vaccine, a major step forward in a fight against a pandemic that has killed more people in the U.S. than any other nation.
“Hope and help are on the way,” Health and Human Services Secretary Alex Azar, a point person in the Trump administration’s push to develop a safeguard against the disease, said the night before.
“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally,” Dr. Albert Bourla, Pfizer Chairman and CEO, said in a statement. Read more…..
Chart of the Day
Ray Dalio, co-chairman and founder at Bridgewater Associates, discusses his career, his views on management strategy, and the outlook for investing in China. He speaks with Bloomberg Opinion columnist Barry Ritholtz at the Bloomberg Opinion Masters in Business event. Ritholtz’s opinions are his own.